REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 5 filers reported holding REGENERON PHARMACEUTICALS in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $7,415,000 | +192.7% | 202 | +220.6% | 0.43% | +353.7% |
| Q3 2016 | $2,533,000 | +68.6% | 63 | +46.5% | 0.10% | +21.8% |
| Q2 2016 | $1,502,000 | -59.5% | 43 | -58.3% | 0.08% | -58.1% |
| Q1 2016 | $3,713,000 | -76.1% | 103 | -66.1% | 0.19% | -67.1% |
| Q2 2015 | $15,508,000 | -68.9% | 304 | -72.5% | 0.57% | -72.8% |
| Q1 2015 | $49,934,000 | +2730.7% | 1,106 | +2472.1% | 2.08% | +3612.5% |
| Q4 2014 | $1,764,000 | -81.9% | 43 | -84.1% | 0.06% | -85.0% |
| Q3 2014 | $9,734,000 | -70.4% | 270 | -76.8% | 0.37% | -73.5% |
| Q2 2014 | $32,936,000 | -9.8% | 1,166 | -4.1% | 1.41% | -31.0% |
| Q1 2014 | $36,514,000 | +103.5% | 1,216 | +86.5% | 2.05% | +78.9% |
| Q4 2013 | $17,946,000 | -42.7% | 652 | -34.9% | 1.14% | -43.8% |
| Q3 2013 | $31,318,000 | -34.8% | 1,001 | -53.2% | 2.04% | -36.6% |
| Q2 2013 | $48,057,000 | – | 2,137 | – | 3.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,137 | $48,057,000 | 3.21% |
| KNIGHT CAPITAL GROUP LLC | 15,600 | $3,508,000 | 0.06% |
| Citadel Advisors | 118,000 | $26,536,000 | 0.05% |
| Timber Hill LLC | 41,800 | $9,400,000 | 0.03% |
| Calamos Advisors LLC | 430 | $3,197,000 | 0.02% |